Sumitomo Pharma Co., Ltd.
4506.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | ¥87,654,000 | ¥11,206,000 | ¥2,415,000 | ¥53,448,000 |
| Dep. & Amort. | ¥5,278,000 | ¥5,203,000 | ¥5,807,000 | ¥6,066,000 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | -¥19,550,000 | -¥17,430,000 | -¥733,000 | ¥183,000 |
| Other Non-Cash | -¥55,165,000 | ¥829,000 | ¥3,520,000 | -¥58,758,000 |
| Operating Cash Flow | ¥18,217,000 | -¥192,000 | ¥11,009,000 | ¥939,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥1,559,000 | -¥2,451,000 | -¥2,375,000 | -¥2,057,000 |
| Net Acquisitions | ¥30,473,000 | -¥1,954,000 | ¥539,000 | -¥539,000 |
| Inv. Purchases | -¥324,000 | -¥462,000 | ¥0 | ¥0 |
| Inv. Sales/Matur. | ¥3,326,000 | ¥108,000 | ¥0 | ¥0 |
| Other Inv. Act. | ¥32,000 | ¥445,000 | ¥4,147,000 | ¥2,588,000 |
| Investing Cash Flow | ¥31,948,000 | -¥4,314,000 | ¥2,311,000 | -¥8,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -¥46,500,000 | ¥3,970,000 | -¥28,271,000 | -¥15,000,000 |
| Stock Issued | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock Repurch. | ¥0 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | ¥0 | -¥1,000 | -¥1,000 | -¥1,000 |
| Other Fin. Act. | -¥688,000 | -¥750,000 | -¥35,263,000 | -¥864,000 |
| Financing Cash Flow | -¥47,188,000 | ¥3,219,000 | -¥63,535,000 | -¥15,865,000 |
| Forex Effect | ¥15,060,000 | -¥1,376,000 | -¥12,062,000 | ¥1,245,000 |
| Net Chg. in Cash | ¥18,037,000 | -¥2,663,000 | -¥62,277,000 | -¥13,689,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥20,453,000 | ¥23,116,000 | ¥85,393,000 | ¥99,082,000 |
| End Cash | ¥38,490,000 | ¥20,453,000 | ¥23,116,000 | ¥85,393,000 |
| Free Cash Flow | ¥17,168,000 | -¥1,666,000 | ¥8,634,000 | -¥1,118,000 |